An autopsy case of a patient with systemic sclerosis who developed marked pulmonary hypertension because of pulmonary tumor thrombotic microangiopathy caused by gastric carcinoma

References

• Galiè N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Rev Esp Cardiol (Engl Ed). 2016;69(2):177.
   PubMed Web of Science ®Google Scholar
• von Herbay A, Illes A, Waldherr R, et al. Pulmonary tumor thrombotic microangiopathy with pulmonary hypertension. Cancer. 1990;66(3):587–592.
   PubMed Web of Science ®Google Scholar
• Chinen K, Tokuda Y, Fujiwara M, et al. Pulmonary tumor thrombotic microangiopathy in patients with gastric carcinoma: an analysis of 6 autopsy cases and review of the literature. Pathol Res Pract. 2010;206(10):682–689.
   Web of Science ®Google Scholar
• Kuwana M. Pulmonary hypertension as one of vascular complications in patients with systemic sclerosis. AJRS. 2014;3(4):498–504.
   Google Scholar
• Price LC, Wells AU, Wort SJ. Pulmonary tumour thrombotic microangiopathy. Curr Opin Pulm Med. 2016;22(5):421–428.
   Web of Science ®Google Scholar
• Uruga H, Fujii T, Kurosaki A, et al. Pulmonary tumor thrombotic microangiopathy: a clinical analysis of 30 autopsy cases. Intern Med. 2013;52(12):1317–1323.
   Web of Science ®Google Scholar
• Ishiguro T, Takayanagi N, Ando M, et al. Pulmonary tumor thrombotic microangiopathy responding to chemotherapy. Nihon Kokyuki Gakkai Zasshi. 2011;49(9):681–687.
   Google Scholar
• Gainza E, Fernández S, Martínez D, et. al. Pulmonary tumor thrombotic microangiopathy: report of 3 cases and review of the literature. Medicine (Baltimore). 2014;93(24):359–363.
   Web of Science ®Google Scholar
• Okubo Y, Wakayama M, Kitahara K, et al. Pulmonary tumor thrombotic microangiopathy induced by gastric carcinoma: morphometric and immunohistochemical analysis of six autopsy cases. Diagn Pathol. 2011;6(1):27.
   Google Scholar
• Abe H, Hino R, Fukayama M. Platelet-derived growth factor-A and vascular endothelial growth factor-C contribute to the development of pulmonary tumor thrombotic microangiopathy in gastric cancer. Virchows Arch. 2013;462(5):523–531.
   Web of Science ®Google Scholar
• Sato N, Tasaki T, Noguchi H, et al. The pathological challenge of establishing a precise diagnosis for pulmonary tumour thrombotic microangiopathy: identification of new diagnostic criteria. Histopathology. 2019;74(6):892–901.
   Web of Science ®Google Scholar
• Abe T, Fukada I, Shiga T, et al. A case of recurrent breast cancer identified by pulmonary tumor thrombotic microangiopathy. Case Rep Oncol. 2017;10(2):620–626.
   Web of Science ®Google Scholar
• Bae K, Kwon WJ, Choi SH, et al. A case report: cavitary infarction caused by pulmonary tumor thrombotic microangiopathy in a patient with pancreatic intraductal papillary mucinous neoplasm. Korean J Radiol. 2015;16(4):936–941.
   Web of Science ®Google Scholar
• Banno A, Chiba K, Kasai H, et al. Ante-mortem diagnosis of pulmonary tumour thrombotic microangiopathy in a patient with unrecognised extramammary Paget's disease. BMJ Case Rep. 2016;2016:bcr2016216666.
   Google Scholar
• Fuchigami S, Tsunoda R, Shimizu H, et al. Pulmonary tumor thrombotic microangiopathy – antemortem diagnosis with pulmonary artery wedge blood cell sampling in a recurrent breast cancer patient. Circ J. 2017;81(12):1959–1960.
   Web of Science ®Google Scholar
• Fujishiro T, Shuto K, Shiratori T, et al. A case report of pulmonary tumor thrombotic microangiopathy (PTTM) caused by esophageal squamous cell carcinoma. Esophagus. 2013;10(4):247–251.
   Web of Science ®Google Scholar
• Fukada I, Araki K, Minatsuki S, et al. Imatinib alleviated pulmonary hypertension caused by pulmonary tumor thrombotic microangiopathy in a patient with metastatic breast cancer. Clin Breast Cancer. 2015;15(2):e167–70.
   Web of Science ®Google Scholar
• Fukada I, Araki K, Kobayashi K, et al. Imatinib could be a new strategy for pulmonary hypertension caused by pulmonary tumor thrombotic microangiopathy in metastatic breast cancer. Springerplus. 2016;5(1):1582.
   Google Scholar
• Godbole R, Ghatol A, Betancourt J, et al. Pulmonary tumor thrombotic microangiopathy: clinical, radiologic, and histologic correlation. J Clin Imaging Sci. 2015;5:44.
   Web of Science ®Google Scholar
• Godbole R, Saggar R, Zider A, et al. Insights on pulmonary tumor thrombotic microangiopathy: a seven-patient case series. Pulm Circ. 2017;7(4):813–820.
   Web of Science ®Google Scholar
• Guimarães MD, Almeida MF, Brelinger A, et al. Diffuse bronchiolitis pattern on a computed tomography scan as a presentation of pulmonary tumor thrombotic microangiopathy: a case report. J Med Case Rep. 2011;5:575.
   Google Scholar
• Higo K, Kubota K, Takeda A, et al. Successful antemortem diagnosis and treatment of pulmonary tumor thrombotic microangiopathy. Intern Med. 2014;53(22):2595–2599.
   Web of Science ®Google Scholar
• Kayatani H, Matsuo K, Ueda Y, et al. Pulmonary tumor thrombotic microangiopathy diagnosed antemortem and treated with combination chemotherapy. Intern Med. 2012;51(19):2767–2770.
   Web of Science ®Google Scholar
• Kitamura A, Nishimura N, Jinta T, et al. A case of pulmonary tumor thrombotic microangiopathy diagnosed by transbronchial lung biopsy and treated with chemotherapy and long-term oxygen and anticoagulation therapies. Case Rep Pulmonol. 2013;2013:259080.
   Google Scholar
• Noguchi S, Imanaga T, Shimizu M, et al. Case of pulmonary tumor thrombotic microangiopathy diagnosed by transbronchial lung biopsy. Nihon Kokyuki Gakkai Zasshi. 2008;46(6):493–496.
   Google Scholar
• Ogawa A, Yamadori I, Matsubara O, et al. Pulmonary tumor thrombotic microangiopathy with circulatory failure treated with imatinib. Intern Med. 2013;52(17):1927–1930.
   Web of Science ®Google Scholar
• Seki Y, Gotou M, Yasuda A, et al. Secondary pulmonary hypertension due to pulmonary tumor thrombotic microangiopathy diagnosed by open lung biopsy. Kyobu Geka. 2011;64(10):916–919. Sep
   Google Scholar
• Takahashi Y, Uruga H, Fujii T, et al. Antemortem diagnosis of pulmonary tumor thrombotic microangiopathy in a patient with recurrent breast cancer: a case report. BMC Cancer. 2016;16(1):666.
   Google Scholar
• Uruga H, Morokawa N, Enomoto T, et al. A case of pulmonary tumor thrombotic microangiopathy associated with lung adenocarcinoma diagnosed by CT-guided lung biopsy. Nihon Kokyuki Gakkai Zasshi. 2008;46(11):928–933.
   Google Scholar
• Yamakawa H, Yoshida M, Yamada M, et al. Pulmonary tumor thrombotic microangiopathy associated with urothelial carcinoma of the urinary bladder: antemortem diagnosis by pulmonary microvascular cytology. Clin Case Rep. 2015;3(9):735–739.
   Web of Science ®Google Scholar
• Amonkar GP, Jashnani KD, Pallewad S. Pulmonary tumor thrombotic microangiopathy in an unknown primary cancer. Lung India. 2014;31(4):410–412.
   Google Scholar
• Hazeki N, Kobayashi K, Yamamoto M, et al. Pulmonary tumor thrombotic microangiopathy associated with cancer of unknown origin. Nihon Kokyuki Gakkai Zasshi. 2009;47(11):1030–1035.
   Google Scholar
• Kumar N, Price LC, Montero MA, et al. Pulmonary tumour thrombotic microangiopathy: unclassifiable pulmonary. hypertension? Eur Respir J. 2015;46(4):1214–1217.
   Web of Science ®Google Scholar
• Seppala N, Cala A, Klebe S. Unusual presentation of pulmonary tumor thrombotic microangiopathy with no detectable primary tumor. J Postgrad Med. 2009;55(1):38–40.
   Web of Science ®Google Scholar
• Ota K, Matsuyama M, Kokuho N, et al. An autopsy case of pulmonary tumor thrombotic microangiopathy complicated with interstitial pneumonia and lipoid pneumonia. Nihon Kokyuki Gakkai Zasshi. 2009;47(6):518–523. Jun
   Google Scholar
• Yasui H, Akamatsu T, Nakamura Y, et al. A case of pulmonary tumor thrombotic microangiopathy induced by early gastric cancer. Nihon Kokyuki Gakkai Zasshi. 2011;49(2):122–127.
   Google Scholar